Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Assets (2019 - 2025)

aTYR PHARMA's Return on Assets history spans 7 years, with the latest figure at 0.78% for Q4 2025.

  • For Q4 2025, Return on Assets fell 6.0% year-over-year to 0.78%; the TTM value through Dec 2025 reached 0.78%, down 6.0%, while the annual FY2025 figure was 0.82%, 19.0% down from the prior year.
  • Return on Assets reached 0.78% in Q4 2025 per ATYR's latest filing, down from 0.76% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.28% in Q4 2021 to a low of 0.78% in Q4 2025.
  • Average Return on Assets over 5 years is 0.52%, with a median of 0.5% recorded in 2022.
  • Peak YoY movement for Return on Assets: rose 18bps in 2022, then plummeted -33bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.28% in 2021, then crashed by -70bps to 0.48% in 2022, then rose by 8bps to 0.45% in 2023, then plummeted by -61bps to 0.72% in 2024, then fell by -8bps to 0.78% in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Return on Assets are 0.78% (Q4 2025), 0.76% (Q3 2025), and 0.7% (Q2 2025).